3 acid repeating units. CA4 was grafted to the prepared mPEG-PLG by Steglich esterification. Briefly, mPEG-PLG (0.100 mmol, 850 mg) and CA4 (1.00 mmol, 286 mg) were dissolved in 30 mL anhydrous DMF in a glass reactor, then DIC (1.20 mmol, 186 μL) and DMAP (0.750 mmol, 91.6 mg) were added. The reaction proceeded at room temperature for 24 h. Then the reaction mixture was precipitated into excess diethyl ether, re-dissolved in DMF, and dialyzed in distilled water. The final product was obtained after lyophilization with a yield of 86%.
Chemical structures of the synthesized mPEG-PLG and mPEG-PLG-g-CA4 were confirmed by 1 
Preparation and characterization of PLG-CA4/DOX
mPEG-PLG-g-CA4 (500 mg) and DOX·HCl (13.0 mg) were dissolved in 50 mL DMF, the mixture was then added to 100 mL distilled water in a dropwise manner under vigorous stirring. The mixture was dialyzed in distilled water and the micelles were obtained after lyophilization.
The hydrodynamic radius (R h ) of the prepared micelles in phosphate buffered saline (PBS, pH 7. 
In vitro release
In vitro release of DOX and CA4 from PLG-CA4/DOX micelles was conducted using a dialysis method. Briefly, 3 mg of PLG-CA4/DOX was dissolved in 5 mL 
H & E analysis
For comparison purposes, mPEG-PLG/DOX was prepared as previously Measurements of tumor volume and body weight were used to evaluate the treatment efficacy and safety, respectively. Photos of mice bearing tumor were taken on day 15.
Tumor volume (V t ) and tumor suppression rate (TSR%) were calculated based on the following equations: dose of 50.0 mg/kg, n = 3, ** p < 0.01, *** p < 0.001.
